Staging liver fibrosis in chronic hepatitis B with T1 relaxation time index on gadoxetic acid‐enhanced MRI: Comparison with aspartate aminotransferase‐to‐platelet ratio index and FIB‐4. Issue 4 (26th August 2016)
- Record Type:
- Journal Article
- Title:
- Staging liver fibrosis in chronic hepatitis B with T1 relaxation time index on gadoxetic acid‐enhanced MRI: Comparison with aspartate aminotransferase‐to‐platelet ratio index and FIB‐4. Issue 4 (26th August 2016)
- Main Title:
- Staging liver fibrosis in chronic hepatitis B with T1 relaxation time index on gadoxetic acid‐enhanced MRI: Comparison with aspartate aminotransferase‐to‐platelet ratio index and FIB‐4
- Authors:
- Yang, Li
Ding, Ying
Rao, Shengxiang
Chen, Caizhong
Wu, Lifang
Sheng, Ruofan
Fu, Caixia
Zeng, Mengsu - Abstract:
- Abstract : Purpose: To assess the accuracy of the T 1 relaxation time index on gadoxetic acid‐enhanced magnetic resonance imaging (MRI) for staging liver fibrosis in chronic hepatitis B (CHB), in comparison and combination with the aspartate aminotransferase‐to‐platelet ratio index (APRI) and fibrosis‐4 (FIB‐4). Materials and Methods: A retrospective study of gadoxetic acid‐enhanced T 1 mapping and serum biochemical tests was performed on 126 CHB patients who underwent gadoxetic acid‐enhanced 1.5T MRI, and the histological score used as the gold standard. The reduction rate of T 1 relaxation time before and 20 minutes after gadoxetic acid injection (Δ T 1, ΔR1%), the contrast uptake rate (KHep ), APRI, and FIB‐4 were calculated. The diagnostic efficacy of Δ T 1, ΔR1%, KHep, APRI, and FIB‐4 for predicting stage 2 or greater (≥S2), stage 3 or greater (≥S3), and stage 4 (S4) was compared. Results: Δ T 1 ( r = −0.513, P < 0.001), ΔR1% ( r = −0.626, P < 0.001), KHep ( r = −0.527, P < 0.001), APRI ( r = 0.519, P < 0.001), and FIB‐4 ( r = 0.476, P < 0.001) correlated significantly with fibrosis stages. Areas under the curves (AUCs) of ΔR1% for detecting ≥S2, ≥S3, and S4 were 0.849, 0.827, and 0.809, which were greater than that of APRI (0.763, 0.745, 0.787) and FIB‐4 (0.727, 0.738, 0.772), but significant difference was found only in discriminating ≥S2 between ΔR1% and FIB‐4 ( P = 0.027). The combination of all five indices performed best, with AUC, sensitivity, andAbstract : Purpose: To assess the accuracy of the T 1 relaxation time index on gadoxetic acid‐enhanced magnetic resonance imaging (MRI) for staging liver fibrosis in chronic hepatitis B (CHB), in comparison and combination with the aspartate aminotransferase‐to‐platelet ratio index (APRI) and fibrosis‐4 (FIB‐4). Materials and Methods: A retrospective study of gadoxetic acid‐enhanced T 1 mapping and serum biochemical tests was performed on 126 CHB patients who underwent gadoxetic acid‐enhanced 1.5T MRI, and the histological score used as the gold standard. The reduction rate of T 1 relaxation time before and 20 minutes after gadoxetic acid injection (Δ T 1, ΔR1%), the contrast uptake rate (KHep ), APRI, and FIB‐4 were calculated. The diagnostic efficacy of Δ T 1, ΔR1%, KHep, APRI, and FIB‐4 for predicting stage 2 or greater (≥S2), stage 3 or greater (≥S3), and stage 4 (S4) was compared. Results: Δ T 1 ( r = −0.513, P < 0.001), ΔR1% ( r = −0.626, P < 0.001), KHep ( r = −0.527, P < 0.001), APRI ( r = 0.519, P < 0.001), and FIB‐4 ( r = 0.476, P < 0.001) correlated significantly with fibrosis stages. Areas under the curves (AUCs) of ΔR1% for detecting ≥S2, ≥S3, and S4 were 0.849, 0.827, and 0.809, which were greater than that of APRI (0.763, 0.745, 0.787) and FIB‐4 (0.727, 0.738, 0.772), but significant difference was found only in discriminating ≥S2 between ΔR1% and FIB‐4 ( P = 0.027). The combination of all five indices performed best, with AUC, sensitivity, and specificity of 0.860, 87.21%, and 72.50% for diagnosing ≥S2, 0.878, 82.81%, and 85.48% for ≥S3, and 0.867, 80.00%, and 83.95% for S4. Conclusion: The gadoxetic acid‐enhanced T 1 relaxation time index appears to be superior to APRI and FIB‐4 for predicting hepatic fibrosis. The combined use of gadoxetic acid‐enhanced T 1 mapping, APRI, and FIB‐4 may be more reliable for staging liver fibrosis in CHB. Level of Evidence: 4 J. Magn. Reson. Imaging 2017;45:1186–1194 … (more)
- Is Part Of:
- Journal of magnetic resonance imaging. Volume 45:Issue 4(2017)
- Journal:
- Journal of magnetic resonance imaging
- Issue:
- Volume 45:Issue 4(2017)
- Issue Display:
- Volume 45, Issue 4 (2017)
- Year:
- 2017
- Volume:
- 45
- Issue:
- 4
- Issue Sort Value:
- 2017-0045-0004-0000
- Page Start:
- 1186
- Page End:
- 1194
- Publication Date:
- 2016-08-26
- Subjects:
- chronic hepatitis B -- gadoxetic acid -- magnetic resonance imaging -- T1 relaxation time -- liver fibrosis -- serum markers
Magnetic resonance imaging -- Periodicals
616 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1522-2586 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/jmri.25440 ↗
- Languages:
- English
- ISSNs:
- 1053-1807
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5010.791000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 11490.xml